MoneyBall Medicine

Guido Lanza: Can AI Prevent Failure in Drug Discovery Pipelines? (AI Biopharma Special Series Episode 5)

Episode Summary

Harry's guest is Guido Lanza, president and CEO of Numerate. They tackle the question: What if the introduction of AI into drug discovery allowed us to create a true learning loop? This is Part 5 of a special six-part series recorded at the AI Applications Summit, produced in Boston by Corey Lane Partners in October 2018.

Episode Notes

Harry's guest is Guido Lanza, president and CEO of Numerate. Together they tackle the question: What if the introduction of AI into drug discovery allowed us to create a true learning loop? This is Part 5 of a special six-part series recorded at the AI Applications Summit, produced in Boston by Corey Lane Partners in October 2018.

How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch: